ENZ Enzo Biochem Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ENZ

Price (delayed)

$2.09

Market cap

$101.83M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.14

Enterprise value

$91.12M

Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and intellectual property through the development of unique diagnostic platform technologies that provide numerous ...

Highlights
Enzo Biochem's debt has decreased by 32% YoY and by 2.6% QoQ
The gross profit has contracted by 11% from the previous quarter and by 8% YoY
Enzo Biochem's quick ratio has decreased by 10% YoY and by 7% from the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.enzo.com
Peers: BRLI RDNT DGX NEO

Key stats

What are the main financial stats of ENZ
Market
Shares outstanding
48.72M
Market cap
$101.83M
Enterprise value
$91.12M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.64
Price to sales (P/S)
0.91
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.82
Earnings
Revenue
$111.6M
EBIT
-$6.77M
EBITDA
-$3.95M
Free cash flow
-$12.08M
Per share
EPS
-$0.14
Free cash flow per share
-$0.25
Book value per share
$1.28
Revenue per share
$2.29
TBVPS
$1.98
Balance sheet
Total assets
$103.9M
Total liabilities
$41.72M
Debt
$20.42M
Equity
$62.19M
Working capital
$37.6M
Liquidity
Debt to equity
0.33
Current ratio
2.52
Quick ratio
1.74
Net debt/EBITDA
2.71
Margins
EBITDA margin
-3.5%
Gross margin
42.5%
Net margin
-5.9%
Operating margin
-9.4%
Efficiency
Return on assets
-6%
Return on equity
-10%
Return on invested capital
-8.1%
Return on capital employed
-8.5%
Return on sales
-6.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ENZ stock price

How has the Enzo Biochem stock price performed over time
Intraday
-1.42%
1 week
-4.57%
1 month
-9.52%
1 year
-31.25%
YTD
-34.89%
QTD
-27.93%

Financial performance

How have Enzo Biochem's revenue and profit performed over time
Revenue
$111.6M
Gross profit
$47.44M
Operating income
-$10.47M
Net income
-$6.56M
Gross margin
42.5%
Net margin
-5.9%
The operating margin has plunged by 109% from the previous quarter
The operating income has plunged by 99% from the previous quarter
The gross profit has contracted by 11% from the previous quarter and by 8% YoY
Enzo Biochem's gross margin has decreased by 7% YoY and by 6% from the previous quarter

Growth

What is Enzo Biochem's growth rate over time

Valuation

What is Enzo Biochem stock price valuation
P/E
N/A
P/B
1.64
P/S
0.91
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.82
The P/B is 36% less than the 5-year quarterly average of 2.6 and 28% less than the last 4 quarters average of 2.3
ENZ's equity is down by 4.5% from the previous quarter and by 4.3% YoY
The P/S is 54% below the 5-year quarterly average of 2.0 and 28% below the last 4 quarters average of 1.3
The company's revenue fell by 6% QoQ

Efficiency

How efficient is Enzo Biochem business performance

Dividends

What is ENZ's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ENZ.

Financial health

How did Enzo Biochem financials performed over time
ENZ's total assets is 149% greater than its total liabilities
The total liabilities has contracted by 14% YoY and by 4.5% from the previous quarter
Enzo Biochem's quick ratio has decreased by 10% YoY and by 7% from the previous quarter
Enzo Biochem's debt is 67% lower than its equity
Enzo Biochem's debt has decreased by 32% YoY and by 2.6% QoQ
The debt to equity has contracted by 28% YoY but it has grown by 3.1% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.